• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[支气管感染中的抗生素策略。罗红霉素的作用]

[Antibiotic strategy in bronchial infections. Role of roxithromycin].

作者信息

Gaillat J

机构信息

Service de Médecine Interne, Centre Hospitalier de la Région Annecéenne, Annecy.

出版信息

Presse Med. 1997 Mar;26 Suppl 2:16-21.

PMID:9113048
Abstract

UNLABELLED

BRONCHIAL SUPERINFECTIONS: Macrolides are first-line antibiotics for acute bronchitis and infectious complications of chronic bronchitis.

PROVEN EFFICACY

Data in the literature on roxithromycin treatment in respiratory tract infections demonstrate to clinical and bacteriological efficacy at high doses comparable with other available antibiotics. ANTIBIOTIC STRATEGY: These results are explained by the bioavailability of roxithromycin, its antibacterial spectrum, and its pharmacokinetic features (high serum peak, high intracellular and extracellular concentrations).

摘要

未标记

支气管感染:大环内酯类药物是急性支气管炎和慢性支气管炎感染性并发症的一线抗生素。

已证实的疗效

关于罗红霉素治疗呼吸道感染的文献数据表明,高剂量时其在临床和细菌学方面的疗效与其他现有抗生素相当。抗生素策略:罗红霉素的生物利用度、抗菌谱及其药代动力学特征(高血清峰浓度、高细胞内和细胞外浓度)解释了这些结果。

相似文献

1
[Antibiotic strategy in bronchial infections. Role of roxithromycin].[支气管感染中的抗生素策略。罗红霉素的作用]
Presse Med. 1997 Mar;26 Suppl 2:16-21.
2
[Experience with rovamycin and roxithromycin in patients with chronic bronchitis in the presence of posttuberculous changes].[罗伐霉素和罗红霉素在患有慢性支气管炎且有结核后改变患者中的应用经验]
Probl Tuberk. 2002(2):27-9.
3
Roxithromycin versus doxycycline in the treatment of acute exacerbations of chronic bronchitis.罗红霉素与强力霉素治疗慢性支气管炎急性加重期的对比研究
Diagn Microbiol Infect Dis. 1992 May-Jun;15(4 Suppl):123S-127S. doi: 10.1016/0732-8893(92)90139-k.
4
Clinical efficacy of azithromycin in lower respiratory tract infections.阿奇霉素治疗下呼吸道感染的临床疗效。
J Chemother. 1993 Feb;5(1):32-6. doi: 10.1080/1120009x.1993.11739206.
5
[Mucoviscidosis. Antibiotic management].[黏液黏稠症。抗生素治疗]
Presse Med. 1997;26(15):727-32.
6
An open evaluation of the efficacy and safety of the new macrolide roxithromycin in the treatment of lower respiratory tract infections and pneumonia in Nigerian patients.
West Afr J Med. 1996 Apr-Jun;15(2):111-6.
7
Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections.阿奇霉素与罗红霉素治疗急性下呼吸道感染的疗效、安全性及耐受性比较
J Antimicrob Chemother. 1996 Jun;37 Suppl C:115-24. doi: 10.1093/jac/37.suppl_c.115.
8
[Antibacterial therapy in infectious bronchial diseases. Recommendations of the German League for control of respiratory tract diseases].
Med Monatsschr Pharm. 1992 Apr;15(4):100-5.
9
Open clinical trial of roxithromycin in patients of Plateau Hospitals, Jos in upper and lower respiratory tract infections.
West Afr J Med. 1995 Oct-Dec;14(4):238-41.
10
Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial.在基层医疗中,罗红霉素治疗急性下呼吸道感染比阿莫西林更好吗?一项双盲随机对照试验。
J Fam Pract. 2002 Apr;51(4):329-36.